Techh.info/techtechnology hourly

Immunotherapy

headlines texts
16.01.2019
13:39 AzoNano.comResearchers Use DNA Origami to Enhance Effectiveness of Antibodies Used in Vaccines and Immunotherapy

Researchers from Karolinska Institutet, in collaboration with scientists at the University of Oslo, have used DNA origami—DNA-based design of precise nanostructures—and demonstrated the...

Скрыть анонс
09:23 News-Medical.NetMD Anderson Cancer Center collaborates with Dragonfly for new immunotherapy drug clinical trials

The University of Texas MD Anderson Cancer Center and Dragonfly Therapeutics, Inc., today announced a strategic collaboration to bring Dragonfly's TriNKET™ immunotherapy drug candidates to patients in clinical trials beginning in 2019.

Скрыть анонс
12.01.2019
07:21 News-Medical.NetNew potential immunotherapy target in pancreatic cancer identified

Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.

Скрыть анонс
03:43 ScienceDaily.comVISTA checkpoint implicated in pancreatic cancer immunotherapy resistance

Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.

Скрыть анонс
11.01.2019
21:32 CancerNetwork.comIs Patient Sex Associated With Immunotherapy Efficacy?

A meta-analysis looked at whether or not the sex of a patient had any association with the efficacy of immunotherapy in advanced cancers.

Скрыть анонс
04:21 ScienceDaily.comUncovering more options in cancer immunotherapy

If scientists want to boost immune cells' ability to kill cancer cells, then vast libraries of small molecules are potentially available. A new paper shows a platform to sort through them, plus validation. One of the hits: IAP antagonist birinapant, which is already in clinical trials (coincidentally).

Скрыть анонс
08.01.2019
12:41 NewYork TimesNonfiction: Could Immunotherapy Offer a Cure for Cancer?

In “The Breakthrough,” Charles Graeber recounts the long history of researchers’ attempts to mobilize the body’s immune system to fight disease.

Скрыть анонс
12:40 International Herald TribuneNonfiction: Could Immunotherapy Offer a Cure for Cancer?

In “The Breakthrough,” Charles Graeber recounts the long history of researchers’ attempts to mobilize the body’s immune system to fight disease.

Скрыть анонс
07.01.2019
23:14 NYT ScienceNonfiction: Could Immunotherapy Offer a Cure for Cancer?

In “The Breakthrough,” Charles Graeber recounts the long history of researchers’ attempts to mobilize the body’s immune system to fight disease.

Скрыть анонс
22:19 NYT HealthNonfiction: Could Immunotherapy Offer a Cure for Cancer?

In “The Breakthrough,” Charles Graeber recounts the long history of researchers’ attempts to mobilize the body’s immune system to fight disease.

Скрыть анонс
09:21 News-Medical.NetGE Healthcare and VUMC announce partnership to enable safer, more precise cancer immunotherapies

GE Healthcare and Vanderbilt University Medical Center today announced a five-year partnership to enable safer and more precise cancer immunotherapies. Multiple diagnostic tools will be developed to help predict both the efficacy of an immunotherapy treatment and its adverse effects for a specific patient before the therapy is administered.

Скрыть анонс
27.12.2018
11:42 Technology.orgYale Cancer Center scientists advise caution in immunotherapy research

In a new study by Yale Cancer Center (YCC), scientists suggest that as the number of clinical trials in cancer

Скрыть анонс
21.12.2018
14:51 Technology.orgFirst Oral Immunotherapy for Peanut Allergy Gets Closer to FDA Vote

After learning their son Andrew had a serious peanut allergy, Jennifer and Daniel Ayala did everything they could

Скрыть анонс
19.12.2018
11:26 Reuters.com HealthMolecular Partners agrees cancer immunotherapy deal with Amgen

Swiss biotechnology company Molecular Partners said it could earn more than $500 million in payments after striking a deal with U.S. drug giant Amgen to work together in cancer immunotherapy.

Скрыть анонс
18.12.2018
16:50 News-Medical.NetMetal-based chemotherapy enhances the effect of cancer immunotherapy

Due to their powerful tumor-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) effect even against dividing healthy cells.

Скрыть анонс
17.12.2018
18:44 CancerNetwork.comImmunotherapeutic Approaches to the Management of Head and Neck Cancer

Experts discuss the PD-1 checkpoint inhibitors nivolumab and pembrolizumab in the management of head and neck cancer, and how to choose between them.

Скрыть анонс
14.12.2018
09:48 News-Medical.NetNew findings could help develop new immunotherapies against cancer

NK cells, or natural killer cells, play an important role in the body's defences against cancer and various infections.

Скрыть анонс
12.12.2018
21:26 Nature.ComAdrenaline fuels a cytokine storm during immunotherapy

Скрыть анонс
11.12.2018
08:22 News-Medical.NetSlow-growing type of glioma may be vulnerable to immunotherapy, suggests study

Immunotherapy has proved effective in treating a number of cancers, but brain tumors have remained stubbornly resistant.

Скрыть анонс
10.12.2018
23:17 ScienceDaily.comSome brain tumors may respond to immunotherapy

A new study suggests that a slow-growing brain tumor arising in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which gives the immune system a boost in fighting cancer.

Скрыть анонс
07.12.2018
19:53 CancerNetwork.comNovel Immunotherapy for Primary Hemophagocytic Lymphohistiocytosis

Results of a study evaluating the safety and efficacy of a promising new agent were presented at ASH 2018.

Скрыть анонс
12:24 JapanTimes.co.jpNobel winner Tasuku Honjo sees bigger role for immunotherapy in battling cancer

Japanese scientist Tasuku Honjo, who jointly won this year’s Nobel Prize in physiology or medicine for his research on the immune system that contributed to ...

Скрыть анонс
05.12.2018
09:34 News-Medical.NetPhysician-scientists present updated efficacy data on CAR T-cell gene immunotherapy

Physician-scientists from Children's Hospital of Philadelphia presented updated efficacy and safety data on Kymriah--the first-ever U.S. Food and Drug Administration approved personalized CAR T-cell gene immunotherapy for aggressive blood cancers at the 60th American Society of Hematology annual meeting, as well as first-of-its-kind research on overcoming CAR T-cell resistance.

Скрыть анонс
04.12.2018
11:17 Technology.orgStudy: Immunotherapy Better than Chemotherapy for Subtype of Head and Neck Cancer

A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San

Скрыть анонс
10:40 News-Medical.NetInternational study increases group of lung cancer patients who may benefit from immunotherapy

The strategy for triggering the patient's own immune system to attack cancer, immunotherapy, is proving effective for more and more tumor types, although to varying degrees.

Скрыть анонс
03.12.2018
22:46 ScienceDaily.comCombination immunotherapy shows high activity against recurrent Hodgkin lymphoma

A new combination of three drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 95 percent of patients with recurrent Hodgkin lymphoma, according to new results.

Скрыть анонс
16:42 News-Medical.NetSSB enters into collaboration with Immunochina to develop new immunotherapy equipment

Sartorius Stedim Biotech, a leading international supplier of the biopharmaceutical industry, through its China affiliate, and Beijing-based Immunochina Pharmaceuticals, announced today that both parties have entered into a collaboration.

Скрыть анонс
30.11.2018
09:28 News-Medical.NetTriple combination cancer immunotherapy improves survival in mouse model of melanoma

Adoptive cell transfer is a promising cancer immunotherapy that involves isolating T cells from cancer patients that are capable of targeting their tumor, selecting the more active T cells and expanding those in the lab, and then transfusing them back into patients.

Скрыть анонс
00:53 ScienceDaily.comTriple combination cancer immunotherapy improves outcomes in preclinical melanoma model

In adoptive cell transfer immunotherapy, T cells able to recognize a tumor are harvested, expanded in the laboratory, and then reintroduced to attack the tumor. However, they often do not persist long enough to finish the job. A triple combination regimen of adoptive T cell transfer, a PIM kinase inhibitor, and a PD1 inhibitor improved T cell persistence and tumor control in a mouse model of melanoma, report investigators.

Скрыть анонс
28.11.2018
17:25 Medscape.ComParadox: Obesity Promotes Tumors but Boosts Immunotherapy

Obesity increases the risk for cancer, but, somewhat paradoxically, cancer patients who are obese and who undergo immunotherapy have better responses.

Скрыть анонс
26.11.2018
21:21 CancerNetwork.comEmerging Targets in Cancer Immunotherapy

Professor Lana E. Kandalaft, PharmD, PhD spoke with Cancer Network about the next generation of cancer immunotherapy.

Скрыть анонс
20:47 CancerNetwork.comDo Targeted Agents Aid Melanoma Immunotherapy?

Guy Ben-Betzalel, MD spoke with Cancer Network about the emerging role of targeted BRAF+MEK inhibition in antitumor immunity.

Скрыть анонс
22.11.2018
13:51 Technology.orgImmunotherapies linked to specific heart complications

In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that

Скрыть анонс
21.11.2018
16:41 Google news HealthDNA Immunotherapy Targets Two Pathologies in Alzheimer's Disease - PrecisionVaccinations

Скрыть анонс
20.11.2018
17:03 FierceBiotech.comStallergenes' allergy immunotherapy hits goal in phase 3

A phase 3 trial of Stallergenes Greer’s treatment for house dust mite-induced allergic rhinitis has met its primary endpoint. The late-phase success sets Stallergenes up to file for FDA approval of oral immunotherapy STAGR320.

Скрыть анонс
09:54 Technology.orgNew immunotherapy improves MS symptoms

A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has improved symptoms and quality

Скрыть анонс
19.11.2018
16:46 Medscape.ComImmunotherapy Adverse Events More Common Than Initially Reported

The rate of immunotherapy adverse events, as evidenced in real world data, is much higher than was previously reported in the pivotal clinical trials of these agents.

Скрыть анонс
15.11.2018
19:58 CancerNetwork.comWhat Immunotherapy Combination Is Best in Metastatic Bladder Cancer?

Extended follow-up from the CheckMate 032 trial showed strong results with three different immunotherapy regimens involving nivolumab and ipilimumab in patients with previously treated metastatic urothelial carcinoma.

Скрыть анонс
19:09 News-Medical.NetCRISPR-based tool shown to enhance cell-based immunotherapy

Researchers have developed a CRISPR-based tool called SLICE that can boost the effectiveness of immune cell therapies.

Скрыть анонс
14.11.2018
22:01 Medscape.ComFecal Transplant May Resolve Immunotherapy-Related Colitis

Colitis associated with the use of checkpoint inhibitors may be managed successfully by fecal microbiota transplant, says a team reporting results in two patients.

Скрыть анонс
00:46 CancerNetwork.comCan Immunotherapy Be Effective in Certain NETs Patients?

In general, NETs are considered an “immunological desert,” but a new study showed some promise for immunotherapy.

Скрыть анонс
13.11.2018
14:16 FightAging.OrgA Popular Science View of Checkpoint Inhibitor Cancer Immunotherapies

Checkpoint inhibitor therapies are a demonstrably successful approach to cancer immunotherapy. They suppress a mechanism that normally restrains immune cells from attacking other cells. This mechanism is abused by cancers, alongside a variety of other ways in which the immune system can be subverted or quieted. Any advanced tumor tends to have evolved into a state in which it is ignored or even helped by the immune system. Checkpoint inhibitor therapies are an improvement on chemotherapy when it comes to the trade-off between harming the cancer and harming the patient, as well as in the odds of success, but still present risks to patients. Immune checkpoints exist to prevent autoimmunity, and rampant autoimmunity can be just as deadly as any cancer. Our usual defence against […]

Скрыть анонс
09:04 News-Medical.NetStudy finds why obesity both fuels cancer growth and helps immunotherapy kill tumors

A groundbreaking new study by UC Davis researchers has uncovered why obesity both fuels cancer growth and allows blockbuster new immunotherapies to work better against those same tumors.

Скрыть анонс
03:44 Gizmag How can obesity both fuel tumor growth and help new immunotherapy drugs work better?


Two new studies have provided compelling insights into the relationship between obesity and cancer. The research reveals fascinatingly paradoxical effects, suggesting obesity can suppress our immune responses to enhance tumor growth, but also improve the efficacy of a new kind of cancer-killing immunotherapy.
.. Continue Reading How can obesity both fuel tumor growth and help new immunotherapy drugs work better? Category: Medical Tags: Cancer Immunotherapy Obesity

Скрыть анонс
12.11.2018
15:09 KoreaTimes.co.krLG Chem to develop cancer immunotherapy drugs

LG Chem has joined forces with U.S.-based pharmaceutical firm Cue Biopharma to develop cancer immunotherapy drugs, the company said Monday

Скрыть анонс
09.11.2018
13:27 Technology.orgNew immunotherapy technique can specifically target tumor cells, UCI study reports

A new immunotherapy screening prototype developed by University of California, Irvine researchers can quickly create individualized cancer treatments

Скрыть анонс
08.11.2018
22:55 CancerNetwork.comStudy Sheds Light on Risk of Liver Injury in Combined Immunotherapy

The frequency of hepatotoxic immune-related adverse events varied in patients receiving one vs multiple chemotherapy agents.

Скрыть анонс
19:52 ScienceDaily.comCombination chemotherapy and immunotherapy effective in Phase II leukemia study

A combination of the standard-of-care chemotherapy drug known as azacitidine, with nivolumab, an immune checkpoint inhibitor, demonstrated an encouraging response rate and overall survival in patients with relapsed or refractory acute myeloid leukemia, according to new findings.

Скрыть анонс
07.11.2018
15:04 News-Medical.NetNew nano-immunotherapy promotes long-term acceptance of transplanted organs

Researchers at the Mount Sinai School of Medicine have developed a new nanotechnology-based immunotherapy that promotes long-term transplant acceptance in an animal model.

Скрыть анонс
11:16 Nanowerk.comNanotechnology-based immunotherapy that promotes organ transplant acceptance

Researchers have developed a novel type of immunotherapy based on innovative nanotechnology that induces long-term organ transplant acceptance in mice. Their study could transform patient care and help to overcome barriers that prevent successful long-term transplant outcomes.

Скрыть анонс
08:28 News-Medical.NetNew immunotherapy screening prototype helps physicians to effectively target tumors

A new immunotherapy screening prototype developed by University of California, Irvine researchers can quickly create individualized cancer treatments that will allow physicians to effectively target tumors without the side effects of standard cancer drugs.

Скрыть анонс
05:21 ScienceDaily.comNanotechnology-based immunotherapy promoting transplant acceptance

Study could transform care for organ transplant recipients.

Скрыть анонс
00:41 ScienceDaily.comNew immunotherapy technique can specifically target tumor cells

A new immunotherapy screening prototype can quickly create individualized cancer treatments that will allow physicians to effectively target tumors without the side effects of standard cancer drugs.

Скрыть анонс
00:01 Phys.orgNew immunotherapy technique can specifically target tumor cells, study reports

A new immunotherapy screening prototype developed by University of California, Irvine researchers can quickly create individualized cancer treatments that will allow physicians to effectively target tumors without the side effects of standard cancer drugs.

Скрыть анонс
06.11.2018
23:59 Medscape.ComOral Immunotherapy Promising for Wheat Allergy

More than half of wheat-allergic children could successfully consume wheat protein at 1 year, but response to oral immunotherapy was lower than for other food allergies, a small study has found.

Скрыть анонс
04:04 ScienceDaily.comFirst-of-its-kind research models immune responses in cellular immunotherapies

Scientists are pursuing a cross-collaborative effort that could potentially change the way cellular immunotherapies such as stem cell transplantation and CAR T-cell therapies are performed.

Скрыть анонс
01.11.2018
17:33 GenEngNews.comConjoined Cells Form a Potent Immunotherapy Combo

Shackled together, stem cells and platelets may help us escape cancer, report UCLA scientists. In the scientists’ new study, the cancer is leukemia, and the defiant ones include a guide, a hematopoietic stem cell (HSC), and a drug carrier, an engineered platelet. The guide brings the duo into bone marrow, and the drug carrier delivers checkpoint inhibition therapy. In experiments with mice that had acute myeloid leukemia, the UCLA team found that their unusual combination therapy halted the disease from developing any further. Of the mice that received the treatment, 87.5 percent were cured by 80 days after the combination cells were injected. Those mice also were all resistant to leukemia cells that were re-injected two months after the 80-day period. Additional details appeared October 29 in the journal Nature Biomedical Engineering , in an article entitled, “ Conjugation of haematopoietic

Скрыть анонс
31.10.2018
21:10 ScienceDaily.comCytokine levels could predict immunotherapy problems

Researchers have identified blood-based biomarkers that may help identify those patients at greatest risk of developing autoimmune side effects from the treatment.

Скрыть анонс
20:39 News-Medical.NetCytokine levels could predict autoimmune reactions to cancer immunotherapy

The development of immunotherapy, which mobilizes the body's own immune system to destroy cancer cells, is one of the greatest advances in cancer treatment, but immunotherapy can cause harm to healthy tissue in some patients.

Скрыть анонс
07:47 News-Medical.NetScientists pinpoint TIM-3 protein as next potential target for immunotherapy treatments

Following the 2018 Nobel Prize for Medicine, global attention is now more than ever turned toward the promise of immunotherapy in oncology. An international team’s work has shed new light on a molecule called TIM-3 that might play a key role in the regulation of the immune response.

Скрыть анонс
07:37 News-Medical.NetScientists find new protein as next potential target for immunotherapy treatments

Scientists and physicians from the Research Institute of the McGill University Health Centre, the Montreal Children's Hospital of the MUHC, and McGill University in collaboration with French teams from AP-HP, Inserm, Université Paris-Descartes and the Imagine Institute at the Necker-Enfants Malades Hospital, have singled out this protein as the next potential target for immunotherapy treatments in patients with cancer and other diseases.

Скрыть анонс
02:43 ScienceDaily.comScientists neutralize reactive nitrogen molecules to enhance cancer immunotherapy

Researchers studying tumors in prostate cancer models found that nitration of an amino acid can inhibit T-cell activation, thwarting the T-cell's ability to kill cancer cells.

Скрыть анонс
02:01 ScienceDaily.comPromising new target for immunotherapy

Researchers have shed new light on a molecule called TIM-3 that might play a key role in the regulation of the immune response.

Скрыть анонс
30.10.2018
10:49 News-Medical.NetScientists find ways to block nitration of amino acids to improve cancer immunotherapy

Immunotherapy -- harnessing T-cells to attack cancer cells in the body -- has given hope to patients who endure round after round of treatment, including chemotherapy, to little effect. For all of its promise, however, immunotherapy still benefits only a minority of patients -- a reality driving research in the field for ways to improve the relatively new approach.

Скрыть анонс
25.10.2018
08:01 Google news Health'Simply cruel': Patient advocates condemn breast cancer immunotherapy hype - HealthNewsReview.org

Скрыть анонс
03:20 Google news Health'Simply cruel': Patient advocates condemn breast cancer immunotherapy hype - HealthNewsReview.org

Скрыть анонс
24.10.2018
21:39 ScienceDaily.comDevice created to deliver immunotherapy without side effects

Scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this device makes it possible to deliver a one-time, sustained-release dose that would eliminate the need for patients to undergo several IV treatments over time.

Скрыть анонс
18:11 CancerNetwork.comCan Immunotherapy Improve Outcomes in Triple-Negative Breast Cancer?

Researchers tested whether combining chemotherapy with immunotherapy would offer improved survival for patients with triple-negative breast cancer.

Скрыть анонс
17:45 GenEngNews.comBreast Cancer Immunotherapy Delivered without Side Effects

While cancer immunotherapy is one of the most exciting new research areas due to the potential it holds for treating tumors that have been resistant to traditional therapies, it often still comes with unwanted side effects. Mitigating these negative reactions is a primary goal of clinicians and scientists. One possible mechanism to help diminish side-effects and off-target effects would be to deliver the drug directly to tumors and cancer cells—a strategy that has been notoriously difficult to accomplish. However now, scientists at the Houston Methodist Research Institute have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. This new direct-to-tumor drug-delivery device makes it possible to deliver a one-time, sustained-release dose that would eliminate the need for patients to undergo several IV treatments over time. This tiny

Скрыть анонс
09:03 News-Medical.NetScientists develop nanodevice to deliver immunotherapy without side effects

Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer.

Скрыть анонс
23.10.2018
18:55 ScienceDaily.comFirst immunotherapy success for triple-negative breast cancer

New research has shown that by using a combination of immunotherapy and chemotherapy the body's own immune system can be tuned to attack triple-negative breast cancer, extending survival.

Скрыть анонс
11:58 MedicalNewsToday.comMedical News Today: Immunotherapy successful against deadly breast cancer

A new trial confirms that a combination of immunotherapy and chemotherapy boosts survival rates for people with triple-negative breast cancer.

Скрыть анонс
10:30 News-Medical.NetAdvanced breast cancer patients can benefit from immunotherapy-chemotherapy combination

Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.

Скрыть анонс
08:16 News-Medical.NetImmunotherapy is better than chemotherapy as first-line treatment for advanced head and neck cancer

Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial.

Скрыть анонс
07:09 News-Medical.NetCancer treatment may undergo a paradigm shift to immunotherapy soon

Immunotherapy when used for cancer treatment could extend life longer finds studies. Experts have explained that until now immunotherapy was reserved as a last resort for most patients and treatment usually comprised of chemotherapy and radiation therapy failing which these were tried. In a pair of clinical trials, researchers have found that using immunotherapy as first line treatment can extend lives of these cancer patients.

Скрыть анонс
22.10.2018
20:29 News-Medical.NetImmunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer

Immunotherapy with pembrolizumab improves survival in patients with head and neck cancer that has recurred or metastasized, according to late-breaking results from the KEYNOTE-048 study reported at the ESMO 2018 Congress in Munich.

Скрыть анонс
18:13 Google news HealthSome patients with metastatic triple negative breast cancer live longer with immunotherapy - Medical Xpress

Скрыть анонс
18:03 CancerNetwork.comCan Patients With HIV and a Cancer Diagnosis Safely Receive Immunotherapy?

Researchers tested whether immunotherapy could be safely used in HIV-positive patients with cancer.

Скрыть анонс
17:04 Google news HealthImmunotherapy scores a first win against some breast cancers - Washington Post

Скрыть анонс
15:08 Google news HealthImmunotherapy extends lives of patients with aggressive breast cancer, study says - USA TODAY

Скрыть анонс
13:22 News-Medical.NetImmunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Pre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major pathological responses in 100% of early-stage colon cancers with mismatch repair deficiencies, according to results reported at ESMO 2018 from the first exploratory phase II trial to investigate this approach.

Скрыть анонс
13:12 Google news HealthImmunotherapy-chemo combo extends life for women with aggressive form of breast cancer, study finds - FOX43.com

Скрыть анонс
11:50 News-Medical.NetImmunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers

Immunotherapy with nivolumab and low-dose ipilimumab could become a new first line treatment in patients with some metastatic colorectal cancers following late-breaking results from the CheckMate-142 trial reported at the ESMO 2018 Congress in Munich.

Скрыть анонс
09:35 News-Medical.NetImmunotherapy increases survival in some patients with metastatic triple negative breast cancer

Immunotherapy improves survival in some patients with metastatic triple negative breast cancer, according to late-breaking results from the IMpassion130 trial reported at the ESMO 2018 Congress in Munich.

Скрыть анонс
09:02 News-Medical.NetImmunotherapy trial offers new hope for people with aggressive breast cancer

There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer.

Скрыть анонс
04:30 Google news HealthImmunotherapy-chemo combo extends life for women with aggressive form of breast cancer, study finds - fox4kc.com

Скрыть анонс
00:51 Google news HealthImmunotherapy-chemo combo extends life for women with aggressive form of breast cancer, study finds - fox2now.com

Скрыть анонс
21.10.2018
14:07 Google news HealthFirst immunotherapy success for triple-negative breast cancer - Medical Xpress

Скрыть анонс
13:33 Google news HealthImmunotherapy scores a first win against some breast cancers - WWLP.com

Скрыть анонс
02:59 Google news HealthImmunotherapy scores a first win against some breast cancers - Washington Post

Скрыть анонс
02:36 Google news HealthNew immunotherapy drug showing promise for aggressive type of breast cancer - CBS News

Скрыть анонс
01:32 Google news HealthImmunotherapy scores a first win against some breast cancers - NBCNews.com

Скрыть анонс
00:33 CNN HealthImmunotherapy-chemo combo extends life for women with aggressive form of breast cancer, study finds

A combination of chemotherapy and immunotherapy added months to the lives of women with triple-negative breast cancer, an aggressive type that attacks women under 50.

Скрыть анонс
00:24 Google news HealthImmunotherapy scores a first win against some breast cancers - NBCNews.com

Скрыть анонс
00:11 Google news HealthImmunotherapy scores a first win against some breast cancers - NBCNews.com

Скрыть анонс
20.10.2018
23:57 Google news HealthImmunotherapy scores a first win against some breast cancers - NBCNews.com

Скрыть анонс
23:11 Google news HealthImmunotherapy scores a first win against some breast cancers - NBCNews.com

Скрыть анонс
22:35 Google news HealthImmunotherapy scores a first win against some breast cancers - Miami Herald

Скрыть анонс
19.10.2018
19:44 News-Medical.NetImmunotherapy medicine found to be effective in treating uveitis

A team of researchers from the UCH CEU's Biomedical Sciences Institute has tested the efficiency of Bevacizumab, medicine used against cancer and in ophtalmology, to treat uveítis, thus stopping the inflammation from spreading.

Скрыть анонс
18.10.2018
14:35 FierceBiotech.comImproving cancer immunotherapy by controlling RNA expression

Scientists have previously managed to control the strength and timing of expression for DNA-based gene therapies, and a group of MIT researchers have now found a way via gene circuit to control the expression of RNA, which they're applying to cancer immunotherapy.

Скрыть анонс
First← Previous12345678910Previous →Last